Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: Comparison with transfected CHO cells

Ron E. Gray, Michael Munks, Ross R. Haynes, George D. Olsen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The major side effect of morphine and its active metabolite, morphine-6-glucuronide (M6G), is respiratory depression, which is mediated by μ opioid receptors in the medulla and pons. Although the effect of morphine on coupling between μ opioid receptors and G proteins has been studied, the effect of M6G on this coupling has not. Therefore, stimulation of guanylyl-5′-O-([γ35S]-thio)-triphosphate ([35S]-GTPγS) binding by these two narcotic analgesic drugs was compared to the μ-specific synthetic opioid peptide [D-Ala2, N-MePhe4, Gly-ol5]enkephalin in Chinese hamster ovarian cells stably transfected with the murine μ opioid receptor and in brainstem membranes prepared from 3-, 7-, and 14-day-old guinea pigs. All three agonists stimulated [35S]-GTPγS binding in transfected cells and neural tissue, and the stimulation was antagonized by naloxone. In brainstem membranes, but not transfected cells, M6G was less efficacious but more potent than morphine, which may be due to differences between murine and guinea pig μ opioid receptors or in the G proteins in these two tissues. Efficacy of the agonists did not change during development, but overall potency decreased between 3 and 14 days after birth. In vivo potency differences for respiratory depression between morphine and M6G are qualitatively similar to in vitro potency differences of these drugs to stimulate [35S]-GTPγS binding in neonatal guinea pig brainstem membranes. Tolerance to opioid effects on [35S]-GTPγS binding developed in transfected cells incubated with morphine with the maximum decrease in potency occurring 18 h later than the maximum decline in efficacy.

Original languageEnglish (US)
Pages (from-to)499-505
Number of pages7
JournalBrain Research Bulletin
Volume54
Issue number5
DOIs
StatePublished - Mar 15 2001

Fingerprint

CHO Cells
mu Opioid Receptor
Morphine
Brain Stem
Opioid Receptors
Guinea Pigs
Membranes
GTP-Binding Proteins
Respiratory Insufficiency
Opioid Peptides
Pons
Enkephalins
Narcotics
Naloxone
Cricetulus
Opioid Analgesics
Analgesics
morphine-6-glucuronide
Parturition
Pharmaceutical Preparations

Keywords

  • Cellular tolerance
  • DAMGO
  • Development
  • GTPγS binding
  • Morphine
  • Respiration

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes : Comparison with transfected CHO cells. / Gray, Ron E.; Munks, Michael; Haynes, Ross R.; Olsen, George D.

In: Brain Research Bulletin, Vol. 54, No. 5, 15.03.2001, p. 499-505.

Research output: Contribution to journalArticle

@article{b5b41b115862465f8920588b4338f62e,
title = "Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: Comparison with transfected CHO cells",
abstract = "The major side effect of morphine and its active metabolite, morphine-6-glucuronide (M6G), is respiratory depression, which is mediated by μ opioid receptors in the medulla and pons. Although the effect of morphine on coupling between μ opioid receptors and G proteins has been studied, the effect of M6G on this coupling has not. Therefore, stimulation of guanylyl-5′-O-([γ35S]-thio)-triphosphate ([35S]-GTPγS) binding by these two narcotic analgesic drugs was compared to the μ-specific synthetic opioid peptide [D-Ala2, N-MePhe4, Gly-ol5]enkephalin in Chinese hamster ovarian cells stably transfected with the murine μ opioid receptor and in brainstem membranes prepared from 3-, 7-, and 14-day-old guinea pigs. All three agonists stimulated [35S]-GTPγS binding in transfected cells and neural tissue, and the stimulation was antagonized by naloxone. In brainstem membranes, but not transfected cells, M6G was less efficacious but more potent than morphine, which may be due to differences between murine and guinea pig μ opioid receptors or in the G proteins in these two tissues. Efficacy of the agonists did not change during development, but overall potency decreased between 3 and 14 days after birth. In vivo potency differences for respiratory depression between morphine and M6G are qualitatively similar to in vitro potency differences of these drugs to stimulate [35S]-GTPγS binding in neonatal guinea pig brainstem membranes. Tolerance to opioid effects on [35S]-GTPγS binding developed in transfected cells incubated with morphine with the maximum decrease in potency occurring 18 h later than the maximum decline in efficacy.",
keywords = "Cellular tolerance, DAMGO, Development, GTPγS binding, Morphine, Respiration",
author = "Gray, {Ron E.} and Michael Munks and Haynes, {Ross R.} and Olsen, {George D.}",
year = "2001",
month = "3",
day = "15",
doi = "10.1016/S0361-9230(01)00427-0",
language = "English (US)",
volume = "54",
pages = "499--505",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes

T2 - Comparison with transfected CHO cells

AU - Gray, Ron E.

AU - Munks, Michael

AU - Haynes, Ross R.

AU - Olsen, George D.

PY - 2001/3/15

Y1 - 2001/3/15

N2 - The major side effect of morphine and its active metabolite, morphine-6-glucuronide (M6G), is respiratory depression, which is mediated by μ opioid receptors in the medulla and pons. Although the effect of morphine on coupling between μ opioid receptors and G proteins has been studied, the effect of M6G on this coupling has not. Therefore, stimulation of guanylyl-5′-O-([γ35S]-thio)-triphosphate ([35S]-GTPγS) binding by these two narcotic analgesic drugs was compared to the μ-specific synthetic opioid peptide [D-Ala2, N-MePhe4, Gly-ol5]enkephalin in Chinese hamster ovarian cells stably transfected with the murine μ opioid receptor and in brainstem membranes prepared from 3-, 7-, and 14-day-old guinea pigs. All three agonists stimulated [35S]-GTPγS binding in transfected cells and neural tissue, and the stimulation was antagonized by naloxone. In brainstem membranes, but not transfected cells, M6G was less efficacious but more potent than morphine, which may be due to differences between murine and guinea pig μ opioid receptors or in the G proteins in these two tissues. Efficacy of the agonists did not change during development, but overall potency decreased between 3 and 14 days after birth. In vivo potency differences for respiratory depression between morphine and M6G are qualitatively similar to in vitro potency differences of these drugs to stimulate [35S]-GTPγS binding in neonatal guinea pig brainstem membranes. Tolerance to opioid effects on [35S]-GTPγS binding developed in transfected cells incubated with morphine with the maximum decrease in potency occurring 18 h later than the maximum decline in efficacy.

AB - The major side effect of morphine and its active metabolite, morphine-6-glucuronide (M6G), is respiratory depression, which is mediated by μ opioid receptors in the medulla and pons. Although the effect of morphine on coupling between μ opioid receptors and G proteins has been studied, the effect of M6G on this coupling has not. Therefore, stimulation of guanylyl-5′-O-([γ35S]-thio)-triphosphate ([35S]-GTPγS) binding by these two narcotic analgesic drugs was compared to the μ-specific synthetic opioid peptide [D-Ala2, N-MePhe4, Gly-ol5]enkephalin in Chinese hamster ovarian cells stably transfected with the murine μ opioid receptor and in brainstem membranes prepared from 3-, 7-, and 14-day-old guinea pigs. All three agonists stimulated [35S]-GTPγS binding in transfected cells and neural tissue, and the stimulation was antagonized by naloxone. In brainstem membranes, but not transfected cells, M6G was less efficacious but more potent than morphine, which may be due to differences between murine and guinea pig μ opioid receptors or in the G proteins in these two tissues. Efficacy of the agonists did not change during development, but overall potency decreased between 3 and 14 days after birth. In vivo potency differences for respiratory depression between morphine and M6G are qualitatively similar to in vitro potency differences of these drugs to stimulate [35S]-GTPγS binding in neonatal guinea pig brainstem membranes. Tolerance to opioid effects on [35S]-GTPγS binding developed in transfected cells incubated with morphine with the maximum decrease in potency occurring 18 h later than the maximum decline in efficacy.

KW - Cellular tolerance

KW - DAMGO

KW - Development

KW - GTPγS binding

KW - Morphine

KW - Respiration

UR - http://www.scopus.com/inward/record.url?scp=0035867046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035867046&partnerID=8YFLogxK

U2 - 10.1016/S0361-9230(01)00427-0

DO - 10.1016/S0361-9230(01)00427-0

M3 - Article

C2 - 11397539

AN - SCOPUS:0035867046

VL - 54

SP - 499

EP - 505

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 5

ER -